MEMPHIS, Tenn. – Several research groups under the auspices of the Association of Biomolecular Resource Facilities are comparing how different microarray platforms stack up when it comes to microRNA analysis.

According to preliminary results of the ongoing study that were presented at ABRF's annual meeting here today, miRNA arrays from Affymetrix, Illumina, Agilent, and Exiqon all show different strengths and shortcomings regarding sensitivity and reproducibility.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.